TEAL VINGER: Open Payments
NPI 1578148284 · FAIRBANKS, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 49 payments from 15 companies in 2025. Trend: 2023 $1,246 · 2024 $1,245 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $243 |
| ABBVIE INC. | 11 | $238 |
| Novo Nordisk Inc | 8 | $185 |
| PFIZER INC. | 6 | $108 |
| Otsuka America Pharmaceutical, Inc. | 2 | $53 |
| Lilly USA, LLC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Rhythm Pharmaceuticals, Inc. | 1 | $27 |
| Exact Sciences Corporation | 1 | $23 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: VRAYLAR, Wegovy, AIRSUPRA, BREZTRI, REXULTI, FARXIGA, PAXLOVID, NURTEC ODT.
Industry payments across AK — which companies pay providers there.
